[Form 4] Berkshire Hills Bancorp, Inc. Insider Trading Activity
Jacqueline Courtwright, Chief Human Resources Officer, reported insider transactions dated 08/29/2025 involving common stock of the issuer noted in this filing. On that date she received 6,413 shares that vested and were transferred to her at no cash cost and sold 3,103 shares at $26.13 per share. After these transactions the filing shows 18,025 shares beneficially owned directly, plus certain indirect holdings including previously granted stock awards and 446 shares held in a 401(k). The filing includes explanations that restricted stock awards granted in January 2023 and January 2024 vested at 100% of target and were transferred on August 29, 2025.
- Vested restricted stock delivered at 100% of target, indicating performance criteria were met for the January 2023 and January 2024 awards
- Clear disclosure of transactions including quantities, vesting explanation, and sale price ($26.13), meeting reporting requirements
- Disposition of 3,103 shares reduces the reporting person's direct holdings, which could modestly lower their share exposure
- Filing lists two different issuer identifiers within the document (issuer line shows Beacon Financial Corp [BBT] while award language references Berkshire Hills Bancorp), which may create ambiguity for readers
Insights
TL;DR: Insider received vested equity and sold a portion the same day, a routine compensation-related liquidity event with limited immediate valuation impact.
The transactions appear to be standard post-vesting activity: restricted shares from prior grants vested at target and were delivered to the executive, increasing direct holdings before an offsetting disposition of 3,103 shares at $26.13. This pattern commonly reflects tax or diversification needs following vesting rather than a signal about firm fundamentals. The filing documents both direct and indirect holdings and quantifies the post-transaction direct ownership.
TL;DR: Vesting and concurrent sale are typical of equity compensation plans; disclosure is complete and timely in this Form 4.
The Form 4 clearly discloses grant vesting details, transfer dates, and the subsequent disposition with price, which satisfies Section 16 reporting requirements. The explanation states the awards vested at 100% of target and were transferred on 08/29/2025. The signature was executed under power of attorney, indicating authorized filing. From a governance perspective, these are routine, documented equity-plan outcomes.